Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Lithium induces autophagy by inhibiting inositol monophosphatase
Sovan Sarkar1,
R. Andres Floto2,
Zdenek Berger1,3,
Sara Imarisio1,3,
Axelle Cordenier1,3,
Matthieu Pasco3,
Lynnette J. Cook1, , and
David C. Rubinsztein1
1 Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 2XY, England, UK 2 Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 2XY, England, UK 3 Department of Genetics, University of Cambridge, Cambridge CB2 3EH, England, UK
Correspondence to David C. Rubinsztein: dcr1000{at}hermes.cam.ac.uk
Abstract:
Macroautophagy is a key pathway for the clearance of aggregate-pronecytosolic proteins. Currently, the only suitable pharmacologicstrategy for up-regulating autophagy in mammalian cells is touse rapamycin, which inhibits the mammalian target of rapamycin(mTOR), a negative regulator of autophagy. Here we describea novel mTOR-independent pathway that regulates autophagy. Weshow that lithium induces autophagy, and thereby, enhances theclearance of autophagy substrates, like mutant huntingtin and-synucleins. This effect is not mediated by glycogen synthasekinase 3ß inhibition. The autophagy-enhancing propertiesof lithium were mediated by inhibition of inositol monophosphataseand led to free inositol depletion. This, in turn, decreasedmyo-inositol-1,4,5-triphosphate (IP3) levels. Our data suggestthat the autophagy effect is mediated at the level of (or downstreamof) lowered IP3, because it was abrogated by pharmacologic treatmentsthat increased IP3. This novel pharmacologic strategy for autophagyinduction is independent of mTOR, and may help treatment ofneurodegenerative diseases, like Huntington's disease, wherethe toxic protein is an autophagy substrate.
Abbreviations used in this paper: 3-MA, 3-methyladenine; 4E-BP1,eukaryotic initiation factor 4E-binding protein 1; CBZ, carbamazepine;EGFP-HDQ74, EGFP-tagged huntingtin exon 1 with 74 polyglutaminerepeats; GSK-3ß, glycogen synthase kinase 3ß;HD, Huntington's disease; IMPase, inositol monophosphatase;IP1-2, inositol mono- and bis-phosphate; IP3, myo-inositol-1,4,5-triphosphate;LC3, microtubule-associated protein 1 light chain 3; mTOR, mammaliantarget of rapamycin; PD, Parkinson's disease; PEI, prolyl endopeptidaseinhibitor; S6P, ribosomal S6 protein.
The editors suggest the following Related Resources on Science sites:
Role of autophagy in prion protein-induced neurodegenerative diseases.
H. Yao, D. Zhao, S. H. Khan, and L. Yang (2013)
Acta Biochim Biophys Sin
45, 494-502
|Abstract »|Full Text »|PDF »
Lithium: a versatile tool for understanding renal physiology.
B. K. Kishore and C. M. Ecelbarger (2013)
Am J Physiol Renal Physiol
304, F1139-F1149
|Abstract »|Full Text »|PDF »
The role of membrane-trafficking small GTPases in the regulation of autophagy.
C. F. Bento, C. Puri, K. Moreau, and D. C. Rubinsztein (2013)
J. Cell Sci.
126, 1059-1069
|Abstract »|Full Text »|PDF »
Hyperactivation of the Mammalian Degenerin MDEG Promotes Caspase-8 Activation and Apoptosis.
J.-A. Pan, Y. Fan, R. K. Gandhirajan, M. Madesh, and W.-X. Zong (2013)
J. Biol. Chem.
288, 2952-2963
|Abstract »|Full Text »|PDF »
Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder.
C.-T. Chiu, Z. Wang, J. G. Hunsberger, and D.-M. Chuang (2013)
Pharmacol. Rev.
65, 105-142
|Abstract »|Full Text »|PDF »
Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid-{beta} Precursor Protein.
C. Parr, R. Carzaniga, S. M. Gentleman, F. Van Leuven, J. Walter, and M. Sastre (2012)
Mol. Cell. Biol.
32, 4410-4418
|Abstract »|Full Text »|PDF »
Expression of a Truncated Form of the Endoplasmic Reticulum Chaperone Protein, {sigma}1 Receptor, Promotes Mitochondrial Energy Depletion and Apoptosis.
N. Shioda, K. Ishikawa, H. Tagashira, T. Ishizuka, H. Yawo, and K. Fukunaga (2012)
J. Biol. Chem.
287, 23318-23331
|Abstract »|Full Text »|PDF »
The Delicate Balance Between Secreted Protein Folding and Endoplasmic Reticulum-Associated Degradation in Human Physiology.
Acetylation: A Novel Link between Double-Strand Break Repair and Autophagy.
G. Shubassi, T. Robert, F. Vanoli, S. Minucci, and M. Foiani (2012)
Cancer Res.
72, 1332-1335
|Abstract »|Full Text »|PDF »
Crohn's disease: NOD2, autophagy and ER stress converge.
T. Fritz, L. Niederreiter, T. Adolph, R. S. Blumberg, and A. Kaser (2011)
Gut
60, 1580-1588
|Abstract »|Full Text »|PDF »
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: Examining a more efficient trial design.
R. G. Miller, D. H. Moore, D. A. Forshew, J. S. Katz, R. J. Barohn, M. Valan, M. B. Bromberg, K. L. Goslin, M. C. Graves, L. F. McCluskey, et al. (2011)
Neurology
77, 973-979
|Abstract »|Full Text »|PDF »
Developing Therapeutic Approaches to Tau, Selected Kinases, and Related Neuronal Protein Targets.
V. M.-Y. Lee, K. R. Brunden, M. Hutton, and J. Q. Trojanowski (2011)
Cold Spring Harb Perspect Med
1, a006437
|Abstract »|Full Text »|PDF »
Relieving Autophagy and 4EBP1 from Rapamycin Resistance.
B. Nyfeler, P. Bergman, E. Triantafellow, C. J. Wilson, Y. Zhu, B. Radetich, P. M. Finan, D. J. Klionsky, and L. O. Murphy (2011)
Mol. Cell. Biol.
31, 2867-2876
|Abstract »|Full Text »|PDF »
A small-molecule enhancer of autophagy decreases levels of A{beta} and APP-CTF via Atg5-dependent autophagy pathway.
Y. Tian, V. Bustos, M. Flajolet, and P. Greengard (2011)
FASEB J
25, 1934-1942
|Abstract »|Full Text »|PDF »
Inhibition of TGFBIp Expression by Lithium: Implications for TGFBI-Linked Corneal Dystrophy Therapy.
S.-I. Choi, B.-Y. Kim, S. Dadakhujaev, J. V. Jester, H. Ryu, T.-i. Kim, and E. K. Kim (2011)
Invest. Ophthalmol. Vis. Sci.
52, 3293-3300
|Abstract »|Full Text »|PDF »
The emerging role of autophagy in alcoholic liver disease.
D-myo-Inositol-3-Phosphate Affects Phosphatidylinositol-Mediated Endomembrane Function in Arabidopsis and Is Essential for Auxin-Regulated Embryogenesis.
Y. Luo, G. Qin, J. Zhang, Y. Liang, Y. Song, M. Zhao, T. Tsuge, T. Aoyama, J. Liu, H. Gu, et al. (2011)
PLANT CELL
23, 1352-1372
|Abstract »|Full Text »|PDF »
Coordination of Autophagy and the Proteasome in Resolving Endoplasmic Reticulum Stress.
Regulation of Mammalian Autophagy in Physiology and Pathophysiology.
B. Ravikumar, S. Sarkar, J. E. Davies, M. Futter, M. Garcia-Arencibia, Z. W. Green-Thompson, M. Jimenez-Sanchez, V. I. Korolchuk, M. Lichtenberg, S. Luo, et al. (2010)
Physiol Rev
90, 1383-1435
|Abstract »|Full Text »|PDF »
Apoptosis and Autophagy: Decoding Calcium Signals that Mediate Life or Death.
M. W. Harr and C. W. Distelhorst (2010)
Cold Spring Harb Perspect Biol
2, a005579
|Abstract »|Full Text »|PDF »
Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L.
K. Matsunaga, E. Morita, T. Saitoh, S. Akira, N. T. Ktistakis, T. Izumi, T. Noda, and T. Yoshimori (2010)
J. Cell Biol.
190, 511-521
|Abstract »|Full Text »|PDF »
An Autophagy-Enhancing Drug Promotes Degradation of Mutant {alpha}1-Antitrypsin Z and Reduces Hepatic Fibrosis.
T. Hidvegi, M. Ewing, P. Hale, C. Dippold, C. Beckett, C. Kemp, N. Maurice, A. Mukherjee, C. Goldbach, S. Watkins, et al. (2010)
Science
329, 229-232
|Abstract »|Full Text »|PDF »
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease.
Chemical Inducers of Autophagy That Enhance the Clearance of Mutant Proteins in Neurodegenerative Diseases.
M. Renna, M. Jimenez-Sanchez, S. Sarkar, and D. C. Rubinsztein (2010)
J. Biol. Chem.
285, 11061-11067
|Abstract »|Full Text »|PDF »
Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines.
J. Fu, C.-J. Shao, F.-R. Chen, H.-K. Ng, and Z.-P. Chen (2010)
Neuro Oncology
12, 328-340
|Abstract »|Full Text »|PDF »
Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview.
M. Mehrpour, A. Esclatine, I. Beau, and P. Codogno (2010)
Am J Physiol Cell Physiol
298, C776-C785
|Abstract »|Full Text »|PDF »
Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays.
V. Mariotti, E. Melissari, S. Amar, A. Conte, R. H. Belmaker, G. Agam, and S. Pellegrini (2010)
Exp Biol Med
235, 300-310
|Abstract »|Full Text »|PDF »
Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3.
F. M. Menzies, J. Huebener, M. Renna, M. Bonin, O. Riess, and D. C. Rubinsztein (2010)
Brain
133, 93-104
|Abstract »|Full Text »|PDF »
Mammalian macroautophagy at a glance.
B. Ravikumar, M. Futter, L. Jahreiss, V. I. Korolchuk, M. Lichtenberg, S. Luo, D. C. O. Massey, F. M. Menzies, U. Narayanan, M. Renna, et al. (2009)
J. Cell Sci.
122, 1707-1711
|Full Text »|PDF »
The mood stabiliser lithium suppresses PIP3 signalling in Dictyostelium and human cells.
J. S. King, R. Teo, J. Ryves, J. V. Reddy, O. Peters, B. Orabi, O. Hoeller, R. S. B. Williams, and A. J. Harwood (2009)
Dis. Model. Mech.
2, 306-312
|Abstract »|Full Text »|PDF »
Nutrient-dependent mTORC1 Association with the ULK1-Atg13-FIP200 Complex Required for Autophagy.
N. Hosokawa, T. Hara, T. Kaizuka, C. Kishi, A. Takamura, Y. Miura, S.-i. Iemura, T. Natsume, K. Takehana, N. Yamada, et al. (2009)
Mol. Biol. Cell
20, 1981-1991
|Abstract »|Full Text »|PDF »
Autophagy in Atherosclerosis: A Cell Survival and Death Phenomenon With Therapeutic Potential.
Loss of Macroautophagy Promotes or Prevents Fibroblast Apoptosis Depending on the Death Stimulus.
Y. Wang, R. Singh, A. C. Massey, S. S. Kane, S. Kaushik, T. Grant, Y. Xiang, A. M. Cuervo, and M. J. Czaja (2008)
J. Biol. Chem.
283, 4766-4777
|Abstract »|Full Text »|PDF »
Lithium delays progression of amyotrophic lateral sclerosis.
F. Fornai, P. Longone, L. Cafaro, O. Kastsiuchenka, M. Ferrucci, M. L. Manca, G. Lazzeri, A. Spalloni, N. Bellio, P. Lenzi, et al. (2008)
PNAS
105, 2052-2057
|Abstract »|Full Text »|PDF »
A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.
S. Sarkar, G. Krishna, S. Imarisio, S. Saiki, C. J. O'Kane, and D. C. Rubinsztein (2008)
Hum. Mol. Genet.
17, 170-178
|Abstract »|Full Text »|PDF »
Induction of Autophagy Does Not Affect Human Rhinovirus Type 2 Production.
M. Brabec-Zaruba, U. Berka, D. Blaas, and R. Fuchs (2007)
J. Virol.
81, 10815-10817
|Abstract »|Full Text »|PDF »
Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and {alpha}-Synuclein.
S. Sarkar, J. E. Davies, Z. Huang, A. Tunnacliffe, and D. C. Rubinsztein (2007)
J. Biol. Chem.
282, 5641-5652
|Abstract »|Full Text »|PDF »
Spatial Expression Patterns and Biochemical Properties Distinguish a Second myo-Inositol Monophosphatase IMPA2 from IMPA1.
T. Ohnishi, H. Ohba, K.-C. Seo, J. Im, Y. Sato, Y. Iwayama, T. Furuichi, S.-K. Chung, and T. Yoshikawa (2007)
J. Biol. Chem.
282, 637-646
|Abstract »|Full Text »|PDF »
Rapamycin alleviates toxicity of different aggregate-prone proteins.
Z. Berger, B. Ravikumar, F. M. Menzies, L. G. Oroz, B. R. Underwood, M. N. Pangalos, I. Schmitt, U. Wullner, B. O. Evert, C. J. O'Kane, et al. (2006)
Hum. Mol. Genet.
15, 433-442
|Abstract »|Full Text »|PDF »